Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Andrew Griffiths reports on results from a small-scale clinical trial showing a potential breakthrough in HIV vaccine development.
Transfusion of lab-grown red blood cells in pioneering clinical trial could revolutionise treatment of rare blood disorders
Caius Gibeily reports on the promising results from a phase I trial which transfused lab-grown red blood cells into healthy patients.
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
By Karen Heathcote We’ve seen and heard plenty about vaccines over the last couple of years, with news outlets all over the world proudly showing images of people receiving their COVID-19 vaccination jabs. However, a new vaccine that is about to enter its next phase of trials in Oxford won’t be administered as an injection…